The FDA has approved the supplemental New Drug Application for XELJANZ® to include additional PRO data in the label.
Our parent company, UnitedHealth Group, has unified all health services businesses under the brand Optum.
View this AHIP-sponsored webinar to learn how to zero in on them before they put their health – and your Star ratings – at risk.
Try one of our patient- reported outcome (PRO) surveys.
Try it now
Please enter your email address below to sign up for our eNewsletter.